FDA inspection
Bristol-Myers Squibb Company: FDA inspection ending Sep 14, 2010
FDA inspection 682482 · No Action Indicated (NAI) · Wallingford, CT
Key facts
| Inspection ID | 682482 |
|---|---|
| Firm | Bristol-Myers Squibb Company |
| FEI number | 1283703 |
| Address | 5 Research Pkwy |
| City | Wallingford |
| State | CT |
| ZIP | 06492 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Sep 14, 2010 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data